Laddar populära aktier...
Redeye updates its view on Xbrane following a Q2 report hinting at accelerating sales but also highl...
Redeye returns with a more detailed take on the Q1 report.
Prospekteringsbolaget Bluelake Mineral (Bluelake) har tagit flera viktiga steg sedan föregående anal...
Northbaze announced yesterday the acquisition of Enter Sales & Distribution AB, a company with three...
Product sales (+13% y-o-y) and new billings (+12%) with the strongest growth rates in 2 years Uncert...
Redeye concludes that Systemair’s Q1 numbers are quite in-line with what we anticipated.
Redeye comments on Fluoguide’s Q2 2024 report, following its recent cSEK60m directed share issue tha...
Redeye comments on Lytix’ second quarter report 2024.
Redeye comments on Scandion Oncology’s Q2 2024 report, shortly after the company announced that its ...
Solid sales growth (14% y-o-y) and positive FCF EBIT estimates down slightly on higher opex in Q2 7-...
Redeye comments on Cantargia's Q2 report. CAN10 is progressing according to plan with proof-of-mecha...
Redeye comments on Verve Group’s Q2 2024 numbers, which align with preliminary figures.
EcoRub (”EcoRub” eller ”bolaget”) publicerade den 28 augusti 2024 bolagets delårsrapport för det and...
Redeye expects the Integrum share to trade down considerably during the day.
Etteplan lowered its guidance as the market conditions have remained weak.
